The purpose of the public workshop is to exchange information with stakeholders from industry, academia, and government about the scientific, clinical, and regulatory challenges encountered in the identification, characterization, and qualification of biomarkers for use in the development of preventive vaccines for infectious diseases indications.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JDNh49
No comments:
Post a Comment